Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #42,651 to #42,700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Diethylcarbamazine warnings and precautions (2 revisions)
  2. Diethylene glycol (2 revisions)
  3. Diethylthiambutene (2 revisions)
  4. Diethyltoluamide (2 revisions)
  5. Dieulafoy's lesion (2 revisions)
  6. Difemerine (2 revisions)
  7. Difetarsone (2 revisions)
  8. Differential diagnosis of signs and symptoms of cardiovascular disease (2 revisions)
  9. Differential diagnosis of ventricular septal defect (2 revisions)
  10. Differentiating Hyperaldosteronism from other diseases (2 revisions)
  11. Differentiating Precocious puberty from other diseases (2 revisions)
  12. Differentiating Psoriasis from other Diseases (2 revisions)
  13. Differentiating Renal osteodystrophy from other diseases (2 revisions)
  14. Differentiating ankylosing spondylitis from other diseases (2 revisions)
  15. Differentiating autoimmune hepatitis differential diagnosis (2 revisions)
  16. Differentiating obesity from other diseases (2 revisions)
  17. Differentiating parotitis from other diseases (2 revisions)
  18. Difficulty walking (2 revisions)
  19. Diffuse axonal injury (2 revisions)
  20. Diffuse esophageal spasm MRI (2 revisions)
  21. Diffuse esophageal spasmmedical therapy (2 revisions)
  22. Diffuse idiopathic skeletal hyperostosis (2 revisions)
  23. Diffuse large B cell lymphoma diagnostic study of choice (2 revisions)
  24. Diffuse neonatal hemangiomatosis (2 revisions)
  25. Diffuse panbronchiolitis CT (2 revisions)
  26. Diffuse panbronchiolitis MRI (2 revisions)
  27. Diffuse panbronchiolitis causes (2 revisions)
  28. Diffuse panbronchiolitis chest x ray (2 revisions)
  29. Diffuse panbronchiolitis classification (2 revisions)
  30. Diffuse panbronchiolitis cost-effectiveness of therapy (2 revisions)
  31. Diffuse panbronchiolitis differential diagnosis (2 revisions)
  32. Diffuse panbronchiolitis future or investigational therapies (2 revisions)
  33. Diffuse panbronchiolitis natural history, complications and prognosis (2 revisions)
  34. Diffuse panbronchiolitis other diagnostic studies (2 revisions)
  35. Diffuse panbronchiolitis other imaging findings (2 revisions)
  36. Diffuse panbronchiolitis physical examination (2 revisions)
  37. Diffuse panbronchiolitis primary prevention (2 revisions)
  38. Diffuse panbronchiolitis risk factors (2 revisions)
  39. Diffuse panbronchiolitis secondary prevention (2 revisions)
  40. Diffusion (2 revisions)
  41. Diffusion MRI (2 revisions)
  42. Diflorasone (patient information) (2 revisions)
  43. Diflucortolone (2 revisions)
  44. Digastric muscle (2 revisions)
  45. Digital Imaging and Communications in Medicine (2 revisions)
  46. Dihexyverine (2 revisions)
  47. Dihydrocodeine (2 revisions)
  48. Dihydroergocryptine (2 revisions)
  49. Dihydroergotamine (2 revisions)
  50. Dihydroetorphine (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)